A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply.

Zhang, KaiTeoh, Jeremydel Pilar Laguna Pes, MariaNg, Chi-Faide la Rosette, Jean J. M. C. H.2023-04-252023-04-252023Zhang, K., Teoh, J., del Pilar Laguna Pes, M., Ng, C. ve de la Rosette, J. J. M. C. H. (2023). A multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply. Journal of Urology, 209(5), 847-848. https://dx.doi.org/10.1097/JU.00000000000034050022-53471527-3792https://dx.doi.org/10.1097/JU.0000000000003405https://hdl.handle.net/20.500.12511/10889To the Editor: We appreciate this opportunity toaddress the concerns in the comment by Jin et al on ourarticle,1evaluating the adverse events and quality of lifeafter irreversible electroporation (IRE) for the ablationof localized low-intermediate risk prostate cancer.eninfo:eu-repo/semantics/embargoedAccessProstate CancerIrreversible ElectroporationAblation of LocalizedA multicenter, randomized, single-blind, 2-arm intervention study evaluating the adverse events and quality of life after irreversible electroporation for the ablation of localized low-intermediate risk prostate cancer. Reply.Letter209584784810.1097/JU.00000000000034052-s2.0-8515217239636927010Q1